What Researchers Did
Researchers explored the effects of Hyperbaric Oxygen Treatment (HBOT) on early breast cancer-related lymphedema and quality of life in women who had undergone surgery, axillary dissection, and radiotherapy.
What They Found
Out of 50 eligible participants, 20 women accepted and 19 completed 40 sessions of HBOT. While objective measures of lymphedema severity (arm mass, volume, lymphatic drainage) did not show consistent changes, participants reported significant improvements in quality of life, including physical functioning, fatigue, insomnia, and breast and arm symptoms, with improvements peaking at 6-month follow-up.
What This Means for Canadian Patients
Canadian patients with breast cancer-related lymphedema might experience improved quality of life symptoms like fatigue and arm discomfort with Hyperbaric Oxygen Treatment, even if objective lymphedema measures don't change significantly. This could offer a practical option for symptom management and overall well-being.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The study was limited by its small sample size and observational design, which restricts the generalizability and definitive conclusions about HBOT's efficacy.